Asthma Control during COVID-19 Lockdown in Patients with Severe Asthma under Biological Drug Treatme...
Asthma Control during COVID-19 Lockdown in Patients with Severe Asthma under Biological Drug Treatment
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Introduction: Coronavirus disease 2019 (COVID-19) has deeply affected the management of patients with severe asthma, treated with add-on biological therapies. Objective: In this study, severe asthmatic patients on treatment with one of three different biologics (omalizumab, mepolizumab, benralizumab) underwent a survey to evaluate the effects of CO...
Alternative Titles
Full title
Asthma Control during COVID-19 Lockdown in Patients with Severe Asthma under Biological Drug Treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f742b3c010d649aeaae676c73487ec27
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f742b3c010d649aeaae676c73487ec27
Other Identifiers
ISSN
2076-3417
E-ISSN
2076-3417
DOI
10.3390/app112412089
